Condition
Paroxysmal Sympathetic Hyperactivity
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Terminated2
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05343988Not ApplicableTerminatedPrimary
Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
NCT06354673Not ApplicableCompletedPrimary
Stellate Ganglion Block Combined With Dexmedetomidine or Subanesthetic Ketamine Infusion for Treatment of Neurostorm.
NCT06090812Completed
Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis
NCT02783105Not ApplicableTerminatedPrimary
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
Showing all 4 trials